Multi-spanning membrane proteins are targets of half of all small molecule drugs but only 3 therapeutic monoclonal antibodies (MAbs).
The Industry Leader in Membrane Protein Solutions
Integral Molecular Earns Back-to-Back Top Workplace Honors from The Philadelphia Inquirer
6/22/2026
USPTO Allows Antibody Genus Claims in Patent Enabled by Integral Molecular’s Paratope-PLUS™ CDR-Scanning
4/21/2026
Integral Molecular Appoints Cheryl Paes as Vice President of Commercial Strategy
3/23/2026
Society of Toxicologic Pathology Symposium
June 21st-June 24th, 2026
San Diego, CA
BIO International
June 22nd-June 25th, 2026
San Diego, CA
American Society for Virology Annual Meeting
July 27th-30th, 2026
University of Minnesota
hubXchange San Francisco
Sep 1st-2nd, 2026
San Francisco, CA
Identification of the Seven Critical Residues that Control ZIKV-DENV Cross-reactivity to Engineer a Non-cross-reactive ZIKV Vaccine
Cell Reports, 2025
Redefining antibody patent protection using paratope mapping and CDR-scanning
Nature Biotechnology, 2025
The emergence of cell-based protein arrays to test for polyspecific off-target binding of antibody therapeutics
mAbs, 2024
THE INDUSTRY LEADER IN MEMBRANE PROTEIN SOLUTIONS
Leading Expertise in Antibodies, Viruses & Membrane Proteins
Integral Molecular is built on innovation and driven to impact the scientific community and
human health. We apply deep expertise in target biology, antibody discovery, virology, and
protein engineering to advance therapies against difficult-to-treat diseases.
Products, Services & Partnering Opportunities
Antibody specificity screening for lead selection & IND safety profiling
Reporter Virus Particles and other tools to expedite vaccine and antibody development
Virus-like particles with the highest level of native membrane proteins for better immunization & screening
Comprehensive Ala-scan epitope mapping service for mechanism-of-action data & stronger IP
Transformative Technologies for Solving Scientific Challenges
Your research deserves a trusted ally. We are problem-solving enthusiasts ready with the right
tools to tackle your biggest scientific challenges.
INDUSTRY EXPERIENCE
Since 2001, Integral Molecular is the industry leader in isolating and characterizing complex membrane proteins.
PROVEN QUALITY
Integral Molecular’s technologies
continuously contribute to scientific discoveries featured in peer-reviewed publications, including in top journals.
OPEN COMMUNICATION
Your success is our priority. We work hard to understand your needs, and we strive to exceed your expectations.
Trusted by Hundreds of Companies Worldwide
Awards
Ready To Get Started?
We have worked with more than 100 top biotech and pharmaceutical companies to help them succeed. Let’s talk about how we can help you.